IP Library › Granted Patent US 7,781,396
Granted Patent B2
US 7,781,396 · App. 11/471,657 · Granted Aug 24, 2010

Peptides directed for diagnosis and treatment of amyloid-associated disease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,781,396
App. No.
11/471,657
Granted
Aug 24, 2010
Kind
B2
Abstract

Peptides having at least 2 amino acids and no more than 15 amino acids are provided. The peptides comprise amino acid sequence X-Y or Y-X, wherein X is an aromatic amino acid and Y is any amino acid other than glycine. Also provided are pharmaceutical compositions and kits including such peptides as well as methods using same for diagnosing and treating amyloid associated diseases.

Claims (2)

1. A synthetic dipeptide as set forth in SEQ ID NO: 145 (D-Trp-Aib).

2. A pharmaceutical composition comprising as an active ingredient a synthetic dipeptide as set forth in SEQ ID NO: 145 (D-Trp-Aib) and a pharmaceutically acceptable carrier or diluent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2006
From: GAZIT, EHUD
To: TEL AVIV UNIVERSITY FUTURE TECHNOLOGY DEVELOPMENT L.P.
Reel/Frame 018032/0148 →